NCT01816165View on ClinicalTrials.gov

Effects of Acipimox on Insulin Action, Vascular Function, and Muscle Function in Type 1 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

June 24, 2015

Study Completion Date

June 24, 2015

Conditions
Type 1 Diabetes
Interventions
DRUG

Acipimox

Subjects will take acipimox 250mg by mouth four times a day for a total of seven days plus one dose the morning of the final study visit day.

DRUG

Placebo

Subjects will take placebo by mouth four times a day for a total of seven days plus one dose the morning of the final study visit day

Trial Locations (1)

80045

University of Colorado Denver, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT01816165 - Effects of Acipimox on Insulin Action, Vascular Function, and Muscle Function in Type 1 Diabetes | Biotech Hunter | Biotech Hunter